A Systematic Review of the Efficacy and Safety of a Purified, Pasteurized C1 Inhibitor Concentrate for the Treatment of Patients With Type I or II Hereditary Angioedema
Allergy, Asthma and Clinical Immunology - United Kingdom
doi 10.1186/1710-1492-6-s1-p32
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2010
Authors
Publisher
Springer Science and Business Media LLC